Please join us for a live webinar on the 24th June 15.00–16.00 at which Professor Axel Behrens (Cancer Research UK Convergence Science Centre Scientific Director) is pleased to host Professor George Hanna and Dr Peter Buckle.
In this series of webinars brought to you by the Cancer Research UK Convergence Science Centre at Imperial College London and The Institute of Cancer Research, London, researchers across the two organisations will discuss key challenges facing cancer research and opportunities for new convergence science approaches to address these. Join us to consider how novel approaches and technologies could shed light on unresolved problems in cancer biology, to innovate new ways to address challenges in cancer and bring pioneering treatments to cancer patients faster.
Professor Hanna will speak on the challenges of cancer early detection and the use of biomarker signatures in disease surveillance. This will be illustrated with examples drawn from his own work on the identification of volatile organic biomarkers of oesophageal cancer in exhaled breath.
Most innovations in healthcare fail. Bioassays rarely make it into clinical practice. Understanding why they fail and then improving the chances of success is what the NIHR funded, London In-vitro diagnostic group are now experts at. This seminar shows what we do, how we do it and why working with us will improve your chances of success. And that the earlier this happens the better. In particular, the seminar will demonstrate the importance of understanding the complexity of the health care system, the human factors that should be considered and the generation of evidence of both the clinical need and the true value to the NHS.
To receive information about how to access this event please email firstname.lastname@example.org
Please note: This webinar is exclusively available only to colleagues across the Institute of Cancer Research, Imperial College London, the Royal Marsden Hospital and Imperial College Healthcare.